PET-MRI scan to study low-grade brain tumors in children
Treatments studied
Part of Cancer clinical trials.
This early-phase study tests how well a special PET-MRI scan (using a radioactive tracer) can find and measure low-grade brain tumors. It may help doctors better track these tumors while you start or continue treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a low-grade brain tumor (WHO grade I–II), involving the brain (not the spinal cord)
- Your MRI shows a measurable tumor area (about 1 by 1 cm) that can be tracked
- You are planning to receive whole-body (systemic) treatment for the tumor
- Your age is 1 to 21 years at the time you enroll
- You can safely handle the scans (the team thinks you can tolerate the imaging)
- You must not be pregnant, and you must be able to avoid close contact with pregnant people or infants for 12 hours after the injection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study uses a special PET scan plus MRI to help doctors tell apart tumor changes in children with aggressive gliomas. It may help find whether treatment is working or if the tumor is progressing, while also mapping tumor activity in the brain.
This study uses a special PET/CT scan to take detailed pictures of your brain tumor. It may help doctors better understand your glioma and plan your treatment.
This study uses special PET and MRI scans to map the activity and oxygen levels of brain tumors (gliomas). The results help doctors plan treatment that is more tailored to each patient.
This trial tests whether a special PET scan can tell the difference between actual tumor growth and treatment-related changes in people with aggressive brain cancer (high-grade glioma). If you have had radiation and an MRI shows a growing lesion, this study may help clarify the cause.
This study tests a special imaging method to look at brain tumors before surgery. It uses a tracer that may help doctors see tumors more clearly.
This Phase 1 study tests a new type of MRI scan using a special “hyperpolarized” imaging agent to help doctors diagnose glioma (a type of brain tumor). It’s mainly focused on whether the scan can safely and clearly show tumor-related information in people who may need treatment.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.